Search

everythinglearnresearchcommunity

for

Search:↓

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Increased cell death and reduced cell growth in hair follicles contribute to baldness.

Reassurance and counseling are key in managing acute telogen effluvium, with supplements possibly offering a placebo effect.

A man's health improved after treating his undiagnosed adrenal insufficiency, which caused fatigue and weight loss.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.

ADAM17 could be a potential target for treating PCOS.

More research is needed to understand sex and racial differences in long COVID.

Excess androgens may cause PCOS, not just be a symptom.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

Stress significantly contributes to hair loss, especially in women and those aged 31-40.

Garudan Kizhangu Ennai may effectively treat alopecia areata but needs more research to confirm its safety and effectiveness.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Zinc acetate hydrate may help reduce fatigue and hair loss in post-COVID-19 patients.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

Melatonin affects certain genes and pathways involved in cashmere goat hair growth.

Melatonin can increase cashmere yield by altering gene expression and restarting the growth cycle early.

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Minoxidil helps lower severe blood pressure and promotes hair growth but can have serious side effects and must be used continuously.

Metabolic syndrome's individual issues are real and need treatment to reduce diabetes and heart disease risks.

Antioxidants may help improve mitochondrial health and could be used to treat diseases related to cell damage.

Skin problems are common in thyroid disorders, with dry skin in hypothyroidism and warm, soft skin in hyperthyroidism.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.